This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
resources:ohdsi_symposium_2017_poster_submissions [2017/09/08 19:45] patrick_ryan [Submissions:] |
resources:ohdsi_symposium_2017_poster_submissions [2017/11/22 19:02] maura_beaton |
||
---|---|---|---|
Line 98: | Line 98: | ||
* Galaznik, Aaron {{:symposium_2017:abstractgalazniksymposium2017_v2.docx|}}: Predictive Modeling as an OHDSI Network Study: Treatment Non-Response in NSCLC patients treated with ALK Inhibitors | * Galaznik, Aaron {{:symposium_2017:abstractgalazniksymposium2017_v2.docx|}}: Predictive Modeling as an OHDSI Network Study: Treatment Non-Response in NSCLC patients treated with ALK Inhibitors | ||
* Yuan,Chi {{:resources:ohdsi_poster_time_generalizability_yuan_5sept2016.pdf|Generalizability of randomized trial follow-up time to real-world practice}} | * Yuan,Chi {{:resources:ohdsi_poster_time_generalizability_yuan_5sept2016.pdf|Generalizability of randomized trial follow-up time to real-world practice}} | ||
+ | * Ames, Michael {{:resources:ohdsi_submission_-_ucdenver_and_google.docx|Google BigQuery and the OHDSI Ecosystem}} | ||
+ | * Kumar, Praveen {{:symposium_2017:kumar_nestsiarovich_hurwitz_lambert.pdf|Visit level suicidality/self-harm phenotyping in bipolar disorder}} | ||
+ | *Lauve, Nicolas {{:symposium_2017:lauve_nelson_young_obenchain_lambert.pdf|Local Control for patient level prediction and heterogeneity of treatment effect}} | ||
+ | * Nestsiarovich, Anastasiya {{:symposium_2017:nestsiarovich_hurwitz_mazurie_nelson_cristanti_tohen_perkins_lambert.pdf|Comparison of 30 bipolar disorder monotherapies for risk of psychiatric hospitalization}} | ||
***SUBMISSIONS CLOSED*** | ***SUBMISSIONS CLOSED*** |